tiprankstipranks
Trending News
More News >
Pharma Foods International Co., Ltd. (JP:2929)
:2929
Japanese Market
Advertisement

Pharma Foods International Co., Ltd. (2929) Ratios

Compare
1 Followers

Pharma Foods International Co., Ltd. Ratios

JP:2929's free cash flow for Q3 2025 was ¥0.79. For the 2025 fiscal year, JP:2929's free cash flow was decreased by ¥ and operating cash flow was ¥-0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.10 1.13 1.03 1.63 2.62
Quick Ratio
0.78 0.88 0.77 1.38 2.03
Cash Ratio
0.49 0.67 0.39 0.89 1.16
Solvency Ratio
0.06 0.14 <0.01 0.32 0.16
Operating Cash Flow Ratio
-0.05 0.25 -0.27 0.54 -0.19
Short-Term Operating Cash Flow Coverage
-0.08 0.33 -0.38 1.73 -0.43
Net Current Asset Value
¥ 882.00M¥ 928.00M¥ -574.00M¥ 5.45B¥ 2.25B
Leverage Ratios
Debt-to-Assets Ratio
0.41 0.55 0.54 0.23 0.35
Debt-to-Equity Ratio
1.30 2.09 2.38 0.58 0.73
Debt-to-Capital Ratio
0.56 0.68 0.70 0.37 0.42
Long-Term Debt-to-Capital Ratio
0.07 0.15 0.09 0.15 0.32
Financial Leverage Ratio
3.18 3.76 4.41 2.47 2.06
Debt Service Coverage Ratio
0.10 0.20 -0.01 1.14 0.66
Interest Coverage Ratio
18.94 75.21 41.54 472.75 87.20
Debt to Market Cap
0.57 0.42 0.40 0.06 0.12
Interest Debt Per Share
459.69 697.59 581.89 168.96 123.52
Net Debt to EBITDA
1.10 0.91 5.01 -0.84 0.29
Profitability Margins
Gross Profit Margin
79.54%80.61%79.93%84.97%79.30%
EBIT Margin
2.66%5.26%2.41%12.36%5.58%
EBITDA Margin
4.28%6.06%2.66%12.52%6.57%
Operating Profit Margin
2.64%5.26%1.79%12.13%4.82%
Pretax Profit Margin
2.54%5.17%2.36%12.33%5.53%
Net Profit Margin
0.37%4.49%-0.62%8.22%4.49%
Continuous Operations Profit Margin
0.36%4.49%-0.62%8.22%4.50%
Net Income Per EBT
14.41%86.98%-26.28%66.63%81.31%
EBT Per EBIT
96.26%98.12%131.76%101.62%114.68%
Return on Assets (ROA)
0.69%8.50%-1.20%18.34%6.83%
Return on Equity (ROE)
1.99%31.99%-5.29%45.39%14.06%
Return on Capital Employed (ROCE)
14.21%30.44%12.91%56.92%10.19%
Return on Invested Capital (ROIC)
0.98%12.01%-1.16%46.58%7.06%
Return on Tangible Assets
0.70%8.56%-1.21%18.50%6.97%
Earnings Yield
0.97%6.37%-0.88%4.56%2.38%
Efficiency Ratios
Receivables Turnover
13.38 14.97 8.11 9.51 6.87
Payables Turnover
9.75 14.19 10.27 8.31 7.08
Inventory Turnover
1.86 2.20 1.99 2.56 1.90
Fixed Asset Turnover
13.14 15.57 13.50 25.86 8.68
Asset Turnover
1.90 1.89 1.93 2.23 1.52
Working Capital Turnover Ratio
20.87 35.40 15.69 8.09 3.36
Cash Conversion Cycle
186.55 164.86 192.82 137.18 194.20
Days of Sales Outstanding
27.28 24.39 45.03 38.39 53.16
Days of Inventory Outstanding
196.69 166.20 183.33 142.74 192.61
Days of Payables Outstanding
37.42 25.73 35.54 43.94 51.57
Operating Cycle
223.98 190.59 228.36 181.13 245.77
Cash Flow Ratios
Operating Cash Flow Per Share
-33.80 212.11 -209.04 204.38 -18.84
Free Cash Flow Per Share
-55.27 198.08 -225.31 198.43 -50.29
CapEx Per Share
21.48 14.03 16.27 5.95 31.45
Free Cash Flow to Operating Cash Flow
1.64 0.93 1.08 0.97 2.67
Dividend Paid and CapEx Coverage Ratio
-0.70 6.23 -4.52 12.83 -0.54
Capital Expenditure Coverage Ratio
-1.57 15.12 -12.85 34.32 -0.60
Operating Cash Flow Coverage Ratio
-0.07 0.30 -0.36 1.21 -0.15
Operating Cash Flow to Sales Ratio
-0.02 0.09 -0.10 0.13 -0.04
Free Cash Flow Yield
-6.94%11.82%-15.40%6.85%-5.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
102.98 15.71 -113.50 21.91 42.04
Price-to-Sales (P/S) Ratio
0.37 0.71 0.71 1.80 1.89
Price-to-Book (P/B) Ratio
2.27 5.03 6.00 9.95 5.91
Price-to-Free Cash Flow (P/FCF) Ratio
-14.40 8.46 -6.49 14.60 -19.87
Price-to-Operating Cash Flow Ratio
-23.70 7.90 -7.00 14.17 -53.03
Price-to-Earnings Growth (PEG) Ratio
-1.15 -0.02 1.03 0.05 1.10
Price-to-Fair Value
2.27 5.03 6.00 9.95 5.91
Enterprise Value Multiple
9.84 12.56 31.54 13.54 29.05
Enterprise Value
26.05B 52.19B 50.46B 79.27B 29.31B
EV to EBITDA
9.84 12.56 31.54 13.54 29.05
EV to Sales
0.42 0.76 0.84 1.70 1.91
EV to Free Cash Flow
-16.22 9.12 -7.72 13.75 -20.07
EV to Operating Cash Flow
-26.53 8.52 -8.32 13.35 -53.57
Tangible Book Value Per Share
347.84 325.25 233.23 284.92 162.16
Shareholders’ Equity Per Share
352.38 333.49 243.68 291.29 169.01
Tax and Other Ratios
Effective Tax Rate
0.86 0.13 1.26 0.33 0.19
Revenue Per Share
2.13K 2.37K 2.07K 1.61K 528.70
Net Income Per Share
7.78 106.70 -12.89 132.20 23.76
Tax Burden
0.14 0.87 -0.26 0.67 0.81
Interest Burden
0.95 0.98 0.98 1.00 0.99
Research & Development to Revenue
0.02 0.01 0.01 0.01 0.03
SG&A to Revenue
0.14 0.06 0.06 0.06 0.06
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-4.35 1.73 -4.26 1.03 -0.64
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis